BPG is committed to discovery and dissemination of knowledge
Articles Published Processes
12/16/2021 7:46:10 AM | Browse: 655 | Download: 1767
 |
Received |
|
2021-09-02 09:07 |
|
Peer-Review Started |
|
2021-09-02 09:10 |
|
First Decision by Editorial Office Director |
|
2021-10-03 18:56 |
|
Return for Revision |
|
2021-10-03 18:56 |
|
Revised |
|
2021-10-15 04:08 |
 |
Publication Fee Transferred |
|
|
|
Second Decision by Editor |
|
2021-12-08 07:01 |
|
Second Decision by Editor-in-Chief |
|
|
|
Final Decision by Editorial Office Director |
|
2021-12-10 03:04 |
|
Articles in Press |
|
2021-12-10 03:04 |
|
Edit the Manuscript by Language Editor |
|
|
|
Typeset the Manuscript |
|
2021-12-13 06:42 |
|
Publish the Manuscript Online |
|
2021-12-16 07:46 |
| ISSN |
1948-9358 (online) |
| Open Access |
This article is an open-access article that was selected by an in-house editor and fully peer-reviewed by external reviewers. It is distributed in accordance with the Creative Commons Attribution NonCommercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See: https://creativecommons.org/Licenses/by-nc/4.0/ |
| Copyright |
© The Author(s) 2021. Published by Baishideng Publishing Group Inc. All rights reserved. |
| Article Reprints |
For details, please visit: http://www.wjgnet.com/bpg/gerinfo/247
|
| Permissions |
For details, please visit: http://www.wjgnet.com/bpg/gerinfo/207
|
| Publisher |
Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA |
| Website |
http://www.wjgnet.com |
| Category |
Endocrinology & Metabolism |
| Manuscript Type |
Retrospective Study |
| Article Title |
Sodium ozagrel and atorvastatin for type 2 diabetes patients with lacunar cerebral infarction
|
| Manuscript Source |
Unsolicited Manuscript |
| All Author List |
You Yu, Lin Wang, Xu Zhu, Ya-Fei Liu and Hai-Ying Ma |
| ORCID |
|
| Funding Agency and Grant Number |
|
| Corresponding Author |
Hai-Ying Ma, MHSc, Chief Pharmacist, Department of Pharmacy, The Fourth Affiliated Hospital of China Medical University, No. 4 Chongshan Road, Huanggu District, Shenyang 110032, Liaoning Province, China. mhy2021888@163.com |
| Key Words |
Sodium ozagrel; Atorvastatin; Type 2 diabetes; Lacunar infarction; Inflammatory response; Nerve damage |
| Core Tip |
This study was performed to observe the effect of sodium ozagrel combined with atorvastatin on high-mobility group protein B1 and high-sensitivity C-reactive protein in patients with type 2 diabetes mellitus and lacunar infarction. The purpose was to find a treatment plan that can effectively inhibit the pathological mechanism, alleviate clinical symptoms, improve the prognosis, and guide clinical treatment. |
| Publish Date |
2021-12-16 07:46 |
| Citation |
Yu Y, Wang L, Zhu X, Liu YF, Ma HY. Sodium ozagrel and atorvastatin for type 2 diabetes patients with lacunar cerebral infarction. World J Diabetes 2021; 12(12): 2096-2106 |
| URL |
https://www.wjgnet.com/1948-9358/full/v12/i12/2096.htm |
| DOI |
https://dx.doi.org/10.4239/wjd.v12.i12.2096 |
All content on this site: Copyright © 1993-2026 Baishideng Publishing Group Inc, its licensors, and contributors. All rights are reserved, including those for text and data mining, AI training, and similar technologies. For all open access content, the relevant licensing terms apply.
